Abstract
Zea mays husk extract and fractions (187–748 mg kg−1) were evaluated for antidiabetic and hypolipidemic potentials in alloxan-induced diabetic rats. Fasting blood glucose (FBG), serum insulin and lipids levels were determined. Treatment of diabetic rats with the extract/fractions caused reduction in FBG with the dichloromethane fraction having the highest activity. The extract/fractions also caused increases in serum insulin levels. The husk extract and fractions further lowered the serum lipids levels with increased HDL-cholesterol level in the treated diabetic rats. Histology of pancreas revealed absence or reductions in pathological signs in the treated diabetic rats.

This publication has 21 references indexed in Scilit: